68.6 F
Laguna Hills
Thursday, Apr 18, 2024
-Advertisement-

HEALTHCARE: JOHN KILCOYNE

CEO, JENAVALVE

WHY: Helms clinical stage medical device maker that aims to compete in the heart stent industry with Edwards Lifesciences, OC’s most valuable publicly traded company.

IN THE NEWS: Attracting heavyweight executives, directors and investors both locally and from Europe. In August, a $100M Series C financing was led by current investor Bain Capital Life Sciences as well as new investors like the Qatar Investment Authority.

QUOTABLE: “JenaValve is committed to becoming the first and only FDA-approved transfemoral transcatheter valve system indicated for symptomatic, severe aortic regurgitation, addressing an estimated multibillion-dollar U.S. market opportunity.”

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Previous article
Next article
-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-